RxDoctor Payments Data

Ann Daleiden, NP

Gerontology · Oakland, CANPI 1093815540

Payments from drug & device makers

$614in general payments, 2019–2025

Across 29 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$177
  • Pfizer$60
  • Boehringer Ingelheim$55
  • AbbVie$48
  • Novo Nordisk$47
  • Collegium Pharmaceutical, Inc.$44
  • plus $182 from 9 others

What the payments were for

  • Food & beverage$60298%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$614 in reported general payments places this provider in the 60th percentile of 348 gerontology providers in California.

See all gerontology providers in California

Medicare billing

Part B allowed, 2024
$142,518
Medicare patients
331
Services billed
1,680

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin75$108,184
EliquisApixaban87$89,308
OzempicSemaglutide71$77,229
GenvoyaElviteg/Cob/Emtri/Tenof Alafen11$50,735
XareltoRivaroxaban37$34,594
JanuviaSitagliptin Phosphate31$33,800
TrulicityDulaglutide22$25,938
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$24,611
ProliaDenosumab12$20,588
MyrbetriqMirabegron15$16,572
Spiriva RespimatTiotropium Bromide20$11,646
Xtampza ErOxycodone Myristate12$8,337
Sumatriptan Succinate53$5,989
Atorvastatin Calcium476$5,344
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen210$4,714

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$55$119,83095 claims
PfizerEliquis$60$89,30887 claims
Novo NordiskOzempic$47$77,22971 claims
Johnson & JohnsonXarelto$17$34,59437 claims
Lilly USA, LLCTrulicity$177$25,93822 claims
AmgenProlia$32$20,58812 claims
Collegium Pharmaceutical, Inc.Xtampza Er$44$8,33712 claims
AbbVieSynthroid$48$1,55120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 348 gerontology providers in California.

Other gerontology in Oakland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →